Biotech Firm OKYO Pharma Closes US$2.5 Million IPO

Biotech firm OKYO Pharma Limited (Nasdaq: OKYO) closed on Thursday its initial public offering on the Nasdaq Capital Market. The firm was able to raise approximately US$2.5 million in its debut on the big board.

The offering consisted of 625,000 American depository shares at US$4.00 per share. The company’s shares are trading under the symbol “OKYO”.

Proceeds of the offering are intended for advancing the firm’s drug candidate OK-101 to filing an investigative new drug application, funding the drug’s phase 2 clinical trial, and for working capital and other general corporate purposes.

ThinkEquity acted as the sole bookrunner for the said offering.

The London-based life sciences company is focused on treating patients suffering from inflammatory eye diseases and ocular pain. It is presently developing its lead preclinical product candidate OK-101 to treat dry-eye disease.

OKYO Pharma last traded at US$3.00 on the Nasdaq.


Information for this briefing was found via Edgar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Tariffs Spark New Race for Critical Metals | Rob McEwen

Antimony Resources: The Bald Hill Project

They Laughed at $3,000 Gold, Now We’re Headed for $4,000! | Sean Roosen – Osisko Development Corp.

Recommended

Steadright Begins Preliminary Economic Assessment On TitanBeach Project

Three Miners Trapped Underground At Newmont’s Red Chris Mine

Related News

ISP Starry Debuts On NYSE Via US$176 Million SPAC Deal

Wireless technology developer and internet service provider Starry, Inc, (NYSE: STRY) made its debut on...

Wednesday, March 30, 2022, 02:26:00 PM

Biopharmaceutical Firm DICE Therapeutics Prices Upsized US$204 Million IPO

Biopharmaceutical company DICE Therapeutics, Inc. (Nasdaq: DICE) started publicly trading on the Nasdaq Global Market...

Thursday, September 16, 2021, 11:08:00 AM

Gaming SPAC UTA Acquisition Prices US$200 Million IPO

Special purpose acquisition company UTA Acquisition Corporation (Nasdaq: UTAAU) started trading publicly on the Nasdaq...

Thursday, December 2, 2021, 02:17:00 PM

SPAC Welsbach Technology Metals Acquisition Prices US$75 Million IPO

Special purpose acquisition company Welsbach Technology Metals Acquisition Corp. (Nasdaq: WTMAU) started trading publicly on...

Wednesday, December 29, 2021, 02:18:00 PM

Investment Management Software Enfusion Prices US$318.75 Million IPO

Accounts payable automation software Enfusion, Inc. (NYSE: ENFN) started publicly trading on the New York...

Thursday, October 21, 2021, 02:19:00 PM